These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15185895)

  • 1. A promising advance in anticoagulant therapy for patients with atrial fibrillation.
    Olsson SB
    Ital Heart J; 2004 May; 5(5):335-9. PubMed ID: 15185895
    [No Abstract]   [Full Text] [Related]  

  • 2. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
    Granger CB; Armaganijan LV
    Circulation; 2012 Jan; 125(1):159-64; discussion 164. PubMed ID: 22215890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.
    Choudhury A; Lip GY
    Age Ageing; 2004 Sep; 33(5):434-6. PubMed ID: 15315915
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Epstein EF
    Age Ageing; 2005 Mar; 34(2):196; author reply 196-7. PubMed ID: 15713873
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation and anticoagulant therapy].
    Mokaddem A; Khouadja MA; Dargouth B; Sdiri W; Joulak A; Saidi I; Selmi K; Makni H; Boujnah MR
    Tunis Med; 2005 Feb; 83 Suppl 2():1-5. PubMed ID: 15991613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation: assessment of benefits and risks].
    von Knorre GH
    Z Gesamte Inn Med; 1993 Sep; 48(9):453-8. PubMed ID: 8212751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel/aspirin combination therapy in high-risk atrial fibrillation patients.
    Cardiovasc J Afr; 2009; 20(3):210. PubMed ID: 19575095
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age and anticoagulant therapy].
    Halinen MO
    Duodecim; 2001; 117(16):1656-62. PubMed ID: 12182105
    [No Abstract]   [Full Text] [Related]  

  • 15. New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.
    Ansell J
    Circulation; 2012 Jan; 125(1):165-70; discussion 170. PubMed ID: 22215891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
    Steinbeck G
    MMW Fortschr Med; 2006 Apr; 148(15):31. PubMed ID: 16711198
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct thrombin inhibitors in atrial fibrillation reloaded.
    Steffel J; Tanner FC
    Eur Heart J; 2009 Dec; 30(23):2832-4. PubMed ID: 19690350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.